Certified by Founder Lodge
Moximed
United Kingdom - Fremont, CA
START UP
1 Disclosed Funding Rounds $40,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Moximed, Inc. is dedicated to improving the standard of care for patients with osteoarthritis (OA). OA, the most common form of arthritis, leads to a breakdown of the joint’s cartilage and of
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 16 ,2022 | Series C | $40,000,000 | |
| August, 14 ,2024 | Series D | $91,000,000.00 |
New Enterprise Associates (NEA)
Gilde Healthcare
Advent Life Sciences
Future Fund
GBS Venture Partners
Morgenthaler
Runway Growth Capital
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
